Each 100 g of cream contains Betamethasone/Neomycin valerate equivalent to Betnovate-N 0.1 g and Neomycin (Betnovate-N) sulfate equivalent to Neomycin (Betnovate-N) 0.3 g.
Prescription: Yes
Warnings: Betnovate-N Cream 25 gm is not recommended for use in diaper rash, diabetes, Cushing's disease (high cortisol levels), pituitary gland diseases, cataract and glaucoma, dehydration, hearing problems (ototoxicity), osteoporosis (weak and brittle bones), muscle weakness, kidney, and gastrointestinal disorders. Prolonged use of steroid containing medicines leads to skin sensitisation and the development of resistant organisms. Ophthalmological (for eye use) preparations of Betnovate-N Cream 25 gm with steroids may cause raised intraocular pressure and cataract formation in the eye. Nasal (for nose use) drops of steroids is not recommended in patients with pulmonary tuberculosis and recent nasal surgery. Ear, eye, nose drops may sometimes contain benzalkonium chloride as a preservative, which is not recommended for use in patients who wear contact lenses.
Avoid applying Betnovate-N Cream 25 gm cream on the sunburns, lesions, blisters and open wounds. Betnovate-N Cream 25 gm may have harmful effects on the baby; hence Betnovate-N Cream 25 gm should be used with caution in pregnancy under your doctor's supervision. Let your doctor know if you plan to become pregnant or already pregnant and a lactating mother. If you apply Betnovate-N Cream 25 gm to breasts or nipple for treatment, wash it off while nursing your baby.
Medicine Interaction: Betnovate-N Cream 25 gm may interact with drugs treating HIV/AIDS (cobicistat), fluid retention drugs (furosemide), antibiotics (bacitracin, polymyxin b), and other corticosteroids.
Drug Schedule: Schedule H Prescription Drug
Side Effects: Betnovate-N: Less Frequent or Rare Incidence: Allergic contact dermatitis (burning and itching of skin, apparent chronic therapeutic failure)- may also be caused by vehicle ingredients, folliculitis, furunculosis, pustules, pyoderma or vesiculation (painful, red or itchy, pus-containing blisters in hair follicles)- more frequent with occlusion or use of ointments in intertriginous areas, hyperesthesia (increased skin sensitivity), numbness in fingers, purpura (blood-containing blisters on skin), skin atrophy (thinning of skin with easy bruising, especially when used on facial or intertriginous area), skin infection, secondary- more frequent with occlusion, stripping of epidermal layer for tape dosage forms, telangiectasis (raises, dark red, wart-like spots on skin, especially when used on the face).
Rare Incidence: With prolonged use or other factors that increase absorption. Acneiform eruptions (acne or oily skin, especially when used on the face), cataracts, posterior subcapsular (gradual blurring or loss of vision)- reported with use of systemic corticosteroids, caution is advised with use of high- and very high-potency topical corticosteroids in periorbital area, cushing's syndrome (backache, filling or rounding out of the face, irritability, menstrual irregularities, mental depressions, in men, unusual decrease in sexual desire or ability, unusual tiredness or weakness), dermatitis, prioral (irritation of skin around mouth), ecchymosis (unusual bruising), edema (increased blood pressure, rapid weight, swelling of feet or lower legs), gastric ulcer (loss of appetite, Nausea, stomach bloating, burning, cramping, or pain, vomiting, weight loss), glaucoma, secondary (eye pain, gradual decrease in vision, Nausea, vomiting)- with use of high- and very high-potency topical corticosteroids in peritoneal area, hirsutism or hypertrichosis (unusual increase in hair growth, especially on the face), hypertension, hypokalemia syndrome (irregular heartbeat, loss of appetite, muscle cramps or pain, Nausea, severe weakness of extremities and trunk, vomiting), hypopigmentation (lightened skin color) or other changes in skin pigmentation, aggravation of infection, miliaria rubra (burning and itching of skin with pinhead-sized red blisters), protein depletion (muscle weakness), skin laceration (tearing of skin), skin maceration (softening of skin), striae (reddish purple lines on arms, face, legs, trunk, or groin), SC tissue atrophy, unusual loss of hair especially on the scalp.
Neomycin (Betnovate-N): More Frequent Incidence: Contact dermatitis (itching, rash, redness, swelling or other sign of skin irritation not present before therapy).
Rare Incidence: Ototoxicity (any loss of hearing).
Those Indicating Need for Medical Attention Only if They Continue or are Bothersome: Less Frequent or Rare Incidence: Burning, dryness, irritation, itching or redness of skin, mild and transient, increased redness or scaling of skin lesions, mild and transient, skin rash, minor and transient.
How to Store it: Store at a temperature not exceeding 25 C. Do not freeze.
Over Dose: Store at a temperature not exceeding 25 C. Do not freeze.
Precautions: Store at a temperature not exceeding 25 C. Do not freeze.
Missed Dose: Store at a temperature not exceeding 25 C. Do not freeze.
